BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35437704)

  • 1. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.
    Xue J; Chen S; Ge D; Yuan X
    Hum Cell; 2022 Jul; 35(4):1174-1191. PubMed ID: 35437704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis.
    Yang CH; Pfeffer SR; Sims M; Yue J; Wang Y; Linga VG; Paulus E; Davidoff AM; Pfeffer LM
    J Biol Chem; 2015 Mar; 290(10):6037-46. PubMed ID: 25589783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
    Ju UI; Park JW; Park HS; Kim SJ; Chun YS
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development.
    Jin Y; Shenoy AK; Doernberg S; Chen H; Luo H; Shen H; Lin T; Tarrash M; Cai Q; Hu X; Fiske R; Chen T; Wu L; Mohammed KA; Rottiers V; Lee SS; Lu J
    Cancer Lett; 2015 Jun; 362(1):70-82. PubMed ID: 25827072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
    Duan S; Cermak L; Pagan JK; Rossi M; Martinengo C; di Celle PF; Chapuy B; Shipp M; Chiarle R; Pagano M
    Nature; 2012 Jan; 481(7379):90-3. PubMed ID: 22113614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.
    Kasuga Y; Ouda R; Watanabe M; Sun X; Kimura M; Hatakeyama S; Kobayashi KS
    Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2218955120. PubMed ID: 37279268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase.
    Rossi M; Duan S; Jeong YT; Horn M; Saraf A; Florens L; Washburn MP; Antebi A; Pagano M
    Mol Cell; 2013 Mar; 49(6):1159-66. PubMed ID: 23478441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.
    Abbas T; Mueller AC; Shibata E; Keaton M; Rossi M; Dutta A
    Mol Cell; 2013 Mar; 49(6):1147-58. PubMed ID: 23478445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.
    Abbas T; Keaton M; Dutta A
    Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail.
    Shao L; Zhang X; Yao Q
    FEBS Open Bio; 2020 Sep; 10(9):1810-1820. PubMed ID: 32657545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-Box Protein 11 Suppresses Cell Proliferation and Aerobic Glycolysis in Glioblastomas by Mediating the Ubiquitin Degradation of Cdc25A.
    Liu C; Chen X; Zhang L; Liu J; Li C; Zhao J; Pu J; Tang P; Liu B; Huang X
    J Neuropathol Exp Neurol; 2022 Jun; 81(7):511-521. PubMed ID: 35582896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
    Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
    Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
    Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
    Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-376a inhibits the proliferation and invasion of osteosarcoma by targeting FBXO11.
    Xu Q; Cheng L; Chen J; Lu W; Wang P
    Hum Cell; 2019 Jul; 32(3):390-396. PubMed ID: 31079326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis.
    Zheng H; Shen M; Zha YL; Li W; Wei Y; Blanco MA; Ren G; Zhou T; Storz P; Wang HY; Kang Y
    Cancer Cell; 2014 Sep; 26(3):358-373. PubMed ID: 25203322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome.
    Schieber M; Marinaccio C; Bolanos LC; Haffey WD; Greis KD; Starczynowski DT; Crispino JD
    Blood Cancer J; 2020 Oct; 10(10):98. PubMed ID: 33024076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
    Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
    Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
    Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
    J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity.
    Abida WM; Nikolaev A; Zhao W; Zhang W; Gu W
    J Biol Chem; 2007 Jan; 282(3):1797-804. PubMed ID: 17098746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.